Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 551

    1.

    The platelet in diabetes: focus on prevention of ischemic events.

    Colwell JA, Nesto RW.

    Diabetes Care. 2003 Jul;26(7):2181-8. Review.PMID: 12832332 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus.

    Colwell JA.

    Am J Cardiovasc Drugs. 2004;4(2):87-106. Review.PMID: 15049721 [PubMed - indexed for MEDLINE]Related articles

    3.

    Antiplatelet therapy and anticoagulation in patients with hypertension.

    Griffin G.

    Am Fam Physician. 2005 Mar 1;71(5):897-9. Review.PMID: 15768617 [PubMed - indexed for MEDLINE]Related articles

    4.

    Update on aspirin in the treatment and prevention of cardiovascular disease.

    Hennekens CH.

    Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.PMID: 12512736 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

    Antithrombotic Trialists' Collaboration.

    BMJ. 2002 Jan 12;324(7329):71-86. Erratum in: BMJ 2002 Jan 19;324(7330):141. PMID: 11786451 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?

    Silva MA, Donovan JL, Gandhi PJ, Volturo GA.

    Vasc Health Risk Manag. 2006;2(1):39-48. Review.PMID: 17319468 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.

    Keller TT, Squizzato A, Middeldorp S.

    Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005158. Review.PMID: 17636787 [PubMed - indexed for MEDLINE]Related articles

    8.

    Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.

    Hankey GJ, Sudlow CL, Dunbabin DW.

    Cochrane Database Syst Rev. 2000;(2):CD001246. Review.PMID: 10796426 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Platelet aggregation inhibitors in diabetes mellitus]

    Abrahamian H.

    Acta Med Austriaca. 1999;26(5):137-41. Review. German. PMID: 11512189 [PubMed - indexed for MEDLINE]Related articles

    10.

    Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation.

    Main C, Palmer S, Griffin S, Jones L, Orton V, Sculpher M, Henderson R, Sudlow C, Hawkins N, Riemsma R.

    Health Technol Assess. 2004 Oct;8(40):iii-iv, xv-xvi, 1-141. Review.PMID: 15461878 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

    Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

    Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.PMID: 15461876 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Role of antiplatelet drugs in the prevention of cardiovascular events.

    Tendera M, Wojakowski W.

    Thromb Res. 2003 Jun 15;110(5-6):355-9. Review.PMID: 14592562 [PubMed - indexed for MEDLINE]Related articles

    13.

    Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.

    Mehta SR, Yusuf S.

    J Am Coll Cardiol. 2003 Feb 19;41(4 Suppl S):79S-88S. Review.PMID: 12644345 [PubMed - indexed for MEDLINE]Related articles

    14.

    Antiplatelet agents and anticoagulants for hypertension.

    Lip GY, Felmeden DC.

    Cochrane Database Syst Rev. 2004;(3):CD003186. Review.PMID: 15266473 [PubMed - indexed for MEDLINE]Related articles

    16.

    Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.

    Bhatt DL, Topol EJ; Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance Executive Committee.

    Am Heart J. 2004 Aug;148(2):263-8.PMID: 15308995 [PubMed - indexed for MEDLINE]Related articles

    17.

    Evidence with antiplatelet therapy and ADP-receptor antagonists.

    Easton JD.

    Cerebrovasc Dis. 2003;16 Suppl 1:20-6. Review.PMID: 12698015 [PubMed - indexed for MEDLINE]Related articles

    18.

    Value of antiplatelet therapy in preventing thrombotic events in generalized vascular disease.

    Montalescot G.

    Clin Cardiol. 2000 Nov;23 Suppl 6:VI-18-22. Review.PMID: 11129682 [PubMed - indexed for MEDLINE]Related articles

    19.

    Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.

    Topol EJ, Easton JD, Amarenco P, Califf R, Harrington R, Graffagnino C, Davis S, Diener HC, Ferguson J, Fitzgerald D, Shuaib A, Koudstaal PJ, Theroux P, Van de Werf F, Willerson JT, Chan R, Samuels R, Ilson B, Granett J.

    Am Heart J. 2000 Jun;139(6):927-33.PMID: 10827369 [PubMed - indexed for MEDLINE]Related articles

    20.

    Managing acute coronary syndrome: evidence-based approaches.

    Spinler SA.

    Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S14-24.PMID: 17519441 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data